直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Justices' Backing of PTAB to Spawn New AIA Review Fights

June 20, 2016

Law360

Following the U.S. Supreme Court's recent first-ever decision on America Invents Act reviews, Law360 interviewed Finnegan partner Erika H. Arner for insight into the decision, which confirmed the PTAB's approach in handling the proceedings. Says Arner, "There are certainly patent owners who will try to turn to Congress as they have before and try to change the rule." She adds, "The effort will be a long process since any bill is unlikely to pass in an election year," adding, "Many big companies have very different positions, and finding common ground will be very difficult in any year, let alone this year. The decision could also spur the courts to take a closer look at the restrictions the PTAB has placed on the ability of patent owners to amend claims in AIA reviews. The PTAB requires patent owners to show that their proposed new claims are patentable, which means that 'it's nearly impossible to amend.' Whether the PTAB's requirements are justified could be the subject of a future Federal Circuit case."

Tags

Supreme Court of the United States (SCOTUS), America Invents Act (AIA), claim amendments

Related Practices

专利局无效程序

PTAB无效程序:双方复审及授权后复审

Related Professionals

Erika Harmon Arner
合伙人
Washington, DC
+1 571 203 2754
Email

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP